Garfield Alastair bought RYTM
July 1, 2026 · Form 4 insider transaction
Garfield Alastair bought 4,445 shares of Rhythm Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
4,445
Price
N/A
Total value
N/A
InsiderGarfield Alastair
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 1, 2026
Filing dateJuly 2, 2026
Shares owned after12,208
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.